Medical Student Jenna Klotz Wins AMA Scholarship
Fourth-year medical student Jenna Klotz has been awarded the Physicians of Tomorrow Scholarship by the American Medical Association (AMA) Foundation.
The scholarship is awarded to a select group of 18 rising fourth-year students based on their academics, financial status and community involvement. Each student will receive a $10,000 scholarship to defray medical school expenses.
"I had to listen to the voicemail a couple times before I believed it, Klotz says of receiving the scholarship.
UC medical student, Jared Bentley, MD, was awarded the scholarship in 2010.
"These medical students represent the very best of the next generation of physicians, said AMA Foundation President Owen Garrick, MD. "Their academic achievements, public health initiatives and volunteer activities illustrate their commitment to assume leadership roles in the medical community and improve health care in the United States.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.